Clinical trial
Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease
NCT00391170 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00391170 |
|---|---|
| Title | Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease |
| Official title | Pilot Study of Topical Dexamethasone 0.01% Solution for Prevention of Oral Chronic Graft Versus Host Disease |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft vs Host Disease |
| Intervention type | Drug |
| Interventions | Topical Dexamethasone, Placebo |
| Enrollment | 62 |
| Start date | Nov 24, 2006 |
| Primary completion | Feb 1, 2021 |
| Completion | Feb 1, 2021 |
| First posted | Oct 23, 2006 |
| Last update posted | Feb 10, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: